Syntropharma

About:

Syntropharma is a specialty pharmaceutical company that develops prescription medicines for diseases affecting the central nervous system.

Website: http://www.syntropharma.com

Top Investors: Highland Capital Partners, TRICAPITAL, Scottish Investment Bank, LINC Scotland

Description:

Syntropharma is an emerging pharmaceutical company focussed on taking commercially successful generic compounds and improving their clinical profile by reformulating them as patch applications which are applied to the skin. Its vision is to develop a stream of first and second to market transdermal products with strong IP that will be out-licensed to pharmaceutical company partners.

Total Funding Amount:

$5.58M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newtown Saint Boswells, Scottish Borders, The, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)syntropharma.com

Founders:

Andrew Gardiner, David McHoul

Number of Employees:

1-10

Last Funding Date:

2012-04-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai